Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

207 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Admission lipoprotein-associated phospholipase A2 activity is not associated with long-term clinical outcomes after ST-segment elevation myocardial infarction.
Woudstra P, Damman P, Kuijt WJ, Kikkert WJ, Grundeken MJ, van Brussel PM, Stroobants AK, van Straalen JP, Fischer JC, Koch KT, Henriques JP, Piek JJ, Tijssen JG, de Winter RJ. Woudstra P, et al. Among authors: fischer jc. PLoS One. 2014 May 1;9(5):e96251. doi: 10.1371/journal.pone.0096251. eCollection 2014. PLoS One. 2014. PMID: 24788873 Free PMC article.
Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T.
Windhausen F, Hirsch A, Fischer J, van der Zee PM, Sanders GT, van Straalen JP, Cornel JH, Tijssen JG, Verheugt FW, de Winter RJ; Invasive versus Conservative Treatment in Unstable Coronary Syndromes (ICTUS) Investigators. Windhausen F, et al. Clin Chem. 2009 Jun;55(6):1118-25. doi: 10.1373/clinchem.2008.119669. Epub 2009 Apr 9. Clin Chem. 2009. PMID: 19359536 Clinical Trial.
Comparison of the usefulness of N-terminal pro-brain natriuretic peptide to other serum biomarkers as an early predictor of ST-segment recovery after primary percutaneous coronary intervention.
Verouden NJ, Haeck JD, Kuijt WJ, van Geloven N, Koch KT, Henriques JP, Baan J, Vis MM, van Straalen JP, Fischer J, Piek JJ, Tijssen JG, de Winter RJ. Verouden NJ, et al. Am J Cardiol. 2010 Apr 15;105(8):1047-52. doi: 10.1016/j.amjcard.2009.12.002. Epub 2010 Feb 20. Am J Cardiol. 2010. PMID: 20381651
Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Haeck JD, Verouden NJ, Kuijt WJ, Koch KT, Van Straalen JP, Fischer J, Groenink M, Bilodeau L, Tijssen JG, Krucoff MW, De Winter RJ. Haeck JD, et al. Am J Cardiol. 2010 Apr 15;105(8):1065-9. doi: 10.1016/j.amjcard.2009.12.003. Epub 2010 Feb 20. Am J Cardiol. 2010. PMID: 20381654 Clinical Trial.
Multiple biomarkers at admission significantly improve the prediction of mortality in patients undergoing primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.
Damman P, Beijk MA, Kuijt WJ, Verouden NJ, van Geloven N, Henriques JP, Baan J, Vis MM, Meuwissen M, van Straalen JP, Fischer J, Koch KT, Piek JJ, Tijssen JG, de Winter RJ. Damman P, et al. J Am Coll Cardiol. 2011 Jan 4;57(1):29-36. doi: 10.1016/j.jacc.2010.06.053. J Am Coll Cardiol. 2011. PMID: 21185497 Free article.
Predictive value of plasma glucose level on admission for short and long term mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Hoebers LP, Damman P, Claessen BE, Vis MM, Baan J Jr, van Straalen JP, Fischer J, Koch KT, Tijssen JG, de Winter RJ, Piek JJ, Henriques JP. Hoebers LP, et al. Am J Cardiol. 2012 Jan 1;109(1):53-9. doi: 10.1016/j.amjcard.2011.07.067. Epub 2011 Sep 23. Am J Cardiol. 2012. PMID: 21944676
207 results